SEC declares Registration Statement on Form S-1 filed by INVO Bioscience

INVO Bioscience, Inc. (OTCBB: IVOB), a medical device company focused on treatment options for patients diagnosed with infertility, announced today that the SEC declared its Registration Statement on Form S-1 filed on December 21, 2009 effective on December 30, 2009.

The Registration Statement becoming effective will satisfy one of the primary conditions in allowing INVO Bioscience to sell securities from time to time to AGS Capital Group, LLC to obtain funding as outlined in the Registration Statement and the 8-K filed November 3, 2009. The Company has submitted an Advance Request this week and anticipates funds from the request on January 8, 2010. "INVO Bioscience now has satisfied the primary condition for our ability to obtain the needed funds to expand sales and execute the business plan," stated Katie Karloff, INVO Bioscience's CEO.